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Abstract
Bacteroides fragilis is the most frequent opportunistic pathogen isolated from
anaerobic infections. However, there is a paucity of information regarding the
genetic and molecular aspects of gene expression of its virulence factors during
extra-intestinal infections. A potential virulence factor that has received little
attention is the ability of B. fragilis to produce hemolysins. In this study, an
implanted perforated table tennis “ping-pong” ball was used as an intra-
abdominal artificial abscess model in the rat. This procedure provided sufficient
infected exudate for gene expression studies in vivo. Real-time reverse transcrip-
tion polymerase chain reaction (RT-PCR) was used to quantify the relative
expression of hlyA, hlyB, hlyC, hlyD, hlyE, hlyF, hlyG, and hlyIII mRNAs. The
hlyA mRNA was induced approximately sixfold after 4 days postinfection
compared with the mRNA levels in the inoculum culture prior to infection.
The hlyB mRNA increased approximately sixfold after 4 days and 12-fold after
8 days postinfection. Expression of hlyC mRNA increased sixfold after 1 day,
45-fold after 4 days, and 16-fold after 8 days postinfection, respectively. The
hlyD and hlyE mRNAs were induced approximately 40-fold and 30-fold, respec-
tively, after 4-days postinfection. The hlyF expression increased approximately
threefold after 4-days postinfection. hlyG was induced approximately fivefold
after 4 and 8 days postinfection. The hlyIII mRNA levels had a steady increase
of approximately four-, eight-, and 12-fold following 1, 4, and 8 days post-
infection, respectively. These findings suggest that B. fragilis hemolysins are
induced and differentially regulated in vivo. Both parent and hlyBA mutant
strains reached levels of approximately 3–8 9 109 cfu/mL after 1 day postinfec-
tion. However, the hlyBA mutant strain lost 2 logs in viable cell counts
compared with the parent strain after 8 days postinfection. This is the first
study showing HlyBA is a virulence factor which plays a role in B. fragilis
survival in an intra-abdominal abscess model.
Introduction
Bacteroides spp. are among the predominant members of
the human colonic microflora which typically reach 1011
colony-forming units (cfu) per gram of stool. They
account for about 30–40% of total bacteria found in the
colon where at least 500–1000 different species have been
so far reported (Savage 1977; Gibson and Roberfroid
1999; Hooper et al. 2002; Eckburg et al. 2005; Smith et al.
2006; Reading and Kasper 2011). Bacteroides vulgatus and
Bacteroides thetaiotaomicron are in general the most com-
mon species isolated from fecal samples. The contribution
of this predominant group of bacteria in the large intes-
tine is related to a variety of physiological functions. As
an example, Bacteroides spp. are directly involved in
several beneficial processes, such as complex polysaccha-
ride degradation, protection of the gut epithelia from
colonization by pathogenic bacteria, development of the
intestinal tract, maturation of the mucosal and systemic
immune systems, bile acid turnover metabolism, energy
326 ª 2013 The Authors. Published by Blackwell Publishing Ltd. This is an open access article under the terms of the Creative
Commons Attribution License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.
harvesting, proteolytic activity, and transformation of
toxic and mutagenic compounds (Bernalier et al. 1999;
Gibson and Roberfroid 1999; Hooper et al. 2002; B€ackhed
et al. 2004; Eckburg et al. 2005; Smith et al. 2006; Turnb-
augh et al. 2006; Neu et al. 2007; Tappenden and Deutsch
2007; Wexler 2007; Neish 2009; Sekirov et al. 2010; Read-
ing and Kasper 2011).
However, this symbiotic relationship is not always
beneficial. In general, Bacteroides opportunistic infections
occur as a consequence of a disruption in the integrity of
the intestinal mucosa wall resulting from conditions such
as gastrointestinal surgery, perforated or gangrenous
appendicitis, perforated ulcer, diverticulitis, trauma, per-
forated colon cancer, and inflammatory bowel diseases
(Johnson et al. 1997; Edmiston et al. 2002). Following
initial bacterial peritoneal contamination, the host
defenses – lymphatic clearance, phagocytosis, and seques-
tration by fibrin – rapidly clear the bacteria within min-
utes via lymphatic system and exposed them to systemic
defenses (McClean et al. 1994; van Till et al. 2007; Mazu-
ski and Solomkin 2009). While most of bacteria are
cleared by host defenses, Bacteroides fragilis emerges as
the most prevalent anaerobic organism in human infec-
tions (Finegold and George 1989; McClean et al. 1994;
Mazuski and Solomkin 2009; Park et al. 2009). Despite
being only 1% or less of the Bacteroides that colonize the
human colon, B. fragilis is by far the most frequent anaer-
obe isolated from anaerobic infections. It accounts for
about 50–70% of all anaerobes isolated from human
infections such as intra-abdominal abscesses, peritonitis,
infections of the female genital tract, deep wounds, brain
abscesses, and bacteremia (Brook 1989; Finegold and
George 1989; Brook and Frazier 2000; Mazuski and
Solomkin 2009; Park et al. 2009). The virulence of B. fragilis
is highlighted by its high frequency of recovery from
blood cultures compared with other species of the genus.
The incidence of anaerobes is 1–17% of all positive blood
cultures (Brook 2010) and the B. fragilis group accounts
for 45% to 65% of nosocomial and community acquired
anaerobic bacteremia (Salonen et al. 1998; Blairon et al.
2006). Bacteroides fragilis alone makes up half to two
thirds of the B. fragilis group species isolated from
patients with anaerobic bacteremia (Nguyen et al. 2000;
Blairon et al. 2006; Brook 2010). Although this incidence
of anaerobic bacteremia is relatively low compared with
all bacteremias, it is associated with a high mortality rate
(Wilson and Limaye 2004; Cheng et al. 2009; Park et al.
2009; Yoshino et al. 2012) of 16% to 45% mortality
(Nguyen et al. 2000; Cheng et al. 2009; Park et al. 2009;
Yoshino et al. 2012). Several factors have to be taken in
consideration when assessing the pathogenic potential of
an organism. With regard to the cases of fatal bacteremia,
B. thetaiotaomicron and Bacteroides (Parabacteroides)
distasonis have a higher (38–100% and 50%, respectively)
mortality rate compared with B. fragilis (24–31%) (Brook
1990). Nonetheless, Bacteroides spp. bacteremia was inde-
pendently associated with a nearly fivefold increase in
relative risk of death (Redondo et al. 1995).
The success of B. fragilis pathogenicity is still not com-
pletely understood but virulence factors such as capsular
polysaccharides, microbial adherence, production of pro-
teases, neuraminidase, an enterotoxin in some strains,
lipopolysaccharides, inhibition of phagocytosis, iron
acquisition, and resistance to oxidative stress play an
important role (Smith et al. 2006; Wexler 2007). The
most studied B. fragilis virulence factor associated with
pathogenicity to date is the production of capsular poly-
saccharide complexes (CPC) and the abscess formation
(Gibson et al. 1998; Krinos et al. 2001). However, strains
lacking CPC are still pathogenic in animal models sug-
gesting that unknown virulence factors still remain to be
determined (Jotwani and Gupta 1991; Jotwani et al.
1992). There are other factors that, although considered
of importance in infections by aerobes and facultative
bacteria, have been given little attention as far as their
role in the pathogenesis of B. fragilis group is concerned.
One such mechanism is the ability of B. fragilis to pro-
duce hemolysins/cytolysins. Microbial hemolysins/cytoly-
sins are considered virulence factors that provide an
advantage to invading microorganisms due to their cyto-
toxic activity of targeting and damaging cell membranes
(Schindel et al. 2001; Aldick et al. 2007). One of their
main functions is to kill leukocytes and enhance bacterial
survival by weakening the host immune response and giv-
ing access to nutrients. In this regard, B. fragilis 638R
contains eight genes homologous to hemolysins but,
despite their virulence potential, their roles and contribu-
tions to Bacteroides pathophysiology in extra-intestinal
survival and infection remain unclear (Robertson et al.
2006).
In this context, it is relevant to demonstrate whether
B. fragilis hemolysins are expressed in vivo and what role
they might play in an experimental model of infection.
Experimental infections with B. fragilis have been carried
out by many investigators using mice, rats, rabbits, and
guinea pigs as animal models (Onderdonk 2005). These
studies have dealt mostly with the ability of B. fragilis to
form abscesses, immune system responses, and evaluation
of antibiotic therapy, but little is known about B. fragilis
gene expression and regulation during extra-intestinal
infection in animal models. Thus, we have adapted the
use of the large rat tissue cage model of infection developed
by Bamberger et al. (2002) as model to study B. fragilis
gene expression in vivo. We have quantified B. fragilis
hemolysin expression by real-time reverse transcription
polymerase chain reaction (RT-PCR) to establish reliable
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and reproducible methods for the detection of B. fragilis
mRNA within the intraperitoneal cavity. We have focused
primarily on the role of the dual-hemolysin components
HlyBA for two reasons: first, it seems to be the major
hemolysin conferring hemolytic activity in B. fragilis 638R
in vitro assays (Robertson et al. 2006). Second, the
regulation of hlyBA mRNA expression in a Fur-dependent
manner is suggestive that this dual hemolysin might be
required in conditions of iron restriction such as it occurs
in host tissues (Robertson et al. 2006). We hope that
these studies may contribute to our understanding of the
pathogenic mechanisms that make this opportunistic
organism to emerge as the number one anaerobic pathogen
in human diseases.
Materials and Methods
Strains and growth conditions
The strains used in this study are listed in Table 1. Bacte-
roides fragilis strains were routinely grown on BHIS (brain
heart infusion supplemented with L-cysteine, hemin, and
NaHCO3). Rifamycin (20 lg/mL), gentamicin (100 lg/mL),
tetracycline (5 lg/mL), and erythromycin (10 lg/mL),
were added to the media when required. For some experi-
ments, strains were grown in chopped meat medium
supplemented with 0.5% glucose, L-cysteine, hemin, and
NaHCO3. Escherichia coli strains were inoculated in Luria
Bertani media supplemented with 100 lg/mL ampicillin,
30 lg/mL kanamycin, or 25 lg/mL chloramphenicol.
Animal model of infection
The large rat tissue cage model, which consists of intra-
peritoneal implantation of the perforated table tennis
“ping-pong” ball, to establish an intraperitoneal abscess
infection was modified from Bamberger et al. (2002).
Experiments were performed with 33 male Sprague Daw-
ley rats (weight, >400 g) obtained from Charles River
Laboratories International, Inc. (Wilmington, MA). The
rats were anesthetized and a single ethylene oxide sterilized
table tennis ball with approximately 250–300 1.5-mm
diameter holes was surgically implanted in the peritoneal
cavity and followed by 4 to 5 weeks for encapsulation.
During this period, the rats were maintained in standard
husbandry procedures. In this model, the ball became
encased in connective tissue, developed blood supply,
and became filled with sterile fluids with the appearance
of serum similar to the same characteristics described by
Bamberger et al. (2002). Following 4–5 weeks, B. fragilis
strains grown overnight in chopped meat media were
diluted in BHIS broth to 108 cfu/mL and this suspen-
sion was used for both in vitro RNA extraction and
inoculate (4 mL) into the encapsulated tissue cage.
Samples from the peritoneal cavity cage were aspirated at
indicated time points for cfu counts and RNA extrac-
tion described below. All procedures involving animals
Table 1. Strains and plasmids used in this study.
Strains Phenotype References
Bacteroides fragilis
638R Clinical isolate, Rif Privitera et al.
1979;
BER-41 638R DhlyBA::tetQ, Rif, Tet Robertson et al.
2006;
BER-45 638R DhlyIII::cfxA, Rif, Cfx Robertson et al.
2006;
BER-47 638R DhlyBA::tetQ,
pER-80, Rif, Tet, Erm
This study
Escherichia coli
DH10B Cloning host strain Invitrogen
Rosetta(DE3)
pLys
Host strain for expression




pET26b(+) Expression vector of target
genes under control of the
T7 promoter and C-terminal
fusion of His-tag to the target
protein
Novagen
pFD340 A Bacteroides–E. coli expression
shuttle vector, (Amp), Erm
Smith et al.
1992;
pER-18 2035-bp DNA fragment
amplified
from 638R chromosome
containing hlyBA ORFs was




pER-80 A 2035 bp BamHI/SstI
promoterless
hlyBA DNA fragment from
pER-18
was cloned into the BamHI/
SstI
sites of the expression
vector pFD340
This study
pER-91 An 816 bp hlyB DNA fragment
amplified
from B. fragilis 638R
chromosome was
cloned into the NdeI/XhoI sites
of pET26b(+)
This study
pER-92 A 1011 bp hlyA DNA fragment
amplified from B. fragilis 638R
chromosome was cloned into
the
NdeI/XhoI sites of pET26b(+)
This study
Erm, erythromycin resistance; Cfx, cefoxitin resistance; Rif, rifampicin
resistance; Tet, tetracycline resistance; Amp, ampicillin resistance.
Parenthesis indicates antibiotic resistance expression in E. coli.
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followed the guidelines given by the National Institutes
of Health Guide for the Care and Use of Laboratory
Animals and approved by the Institutional Review Board
and Animal Care and Use Committee of East Carolina
University.
Bacterial viable counts in the abscess
content
After the inoculation, 0.3–0.4 mL fluid was drawn from
the tissue cage balls at intervals of 1, 4, 8, 15, and 22 days
postinfection. A 100 lL aliquots of the aspirated fluids
were serially diluted in BHIS broth and dilutions were
plated on BHIS incubated in anaerobic chamber incuba-
tor at 37°C. After 4–5 days of incubation, cfu/mL was
determined. Plates were also incubated aerobically as
control for possible abscess contamination.
Total RNA extraction and real-time RT-PCR
The exudates were aspirated (2–3 mL) from the implanted
tissue cage balls at the time points indicated above and
immediately mixed with RNAlater (Ambion Inc., Austin,
TX) at 1:2 ratio. Then a differential lysis using 0.1% sodium
deoxycholate was used to lysis host cells. Sodium deoxych-
olate at 0.2% was used in some extractions. Bacterial pellet
and debris were washed once with phosphate buffer saline
(PBS; 50 mmol/L phosphate buffer, pH 7.4, 150 mmol/L
NaCl):RNAlater solution at 1:2 ratio containing 0.1%
sodium deoxycholate. Total RNA was extracted from the
pellet using the hot phenol method described previously
(Rocha and Smith 1997) and stored in 100% formamide at
70°C. Total RNA was cleaned using the RNeasy Mini kit
(Qiagen, Valencia, CA) according to manufacturer instruc-
tions. RNA was DNAse treated using the Ambion DNA-
free protocol (Ambion, Inc.). First strand cDNA synthesis
was carried out from 1 lL total RNA at 1 lg/lL with ran-
dom hexamer primers and Superscript III RT kit (Invitro-
gen Inc., Carlsbad, CA) according to manufacturer’s
instructions. Real-time PCR quantification of each hemoly-
sin mRNA was performed with 1 lL cDNA sample diluted
1:10 and forward and reverse primers described in Table
S1. Real-time PCR efficiencies were performed for each pri-
mer set. Total RNA obtained from the bacterial inoculum
suspension was used as in vitro control for gene expression.
Data were analyzed using the Relative Expression Software
Tool (REST) 2008 V2.0.7 for group-wise comparison and
statistical analysis of relative expression level results in real-
time PCR (Pfaffl et al. 2002). In vivo fold induction of each
hemolysin was correlated to their respective fold induction
of expression in the inoculum culture in vitro. The 16S
rRNA was used as reference to normalize gene expression
to a housekeeping gene.
Construction and purification of HlyA-His6-
Tag and HlyB-His6-Tag recombinant proteins
A 1011 nt DNA fragment encoding the entire hlyA open
reading frame (ORF) was amplified by PCR using the pri-
mer HlyA-NdeI-FOR (CTAACAAAGCATATGGAAG) and
HlyA-XhoI-REV (ATCGCACTCGAGACGGGAACAGTCT
TCC). The amplified fragment was cloned in-frame into
the NdeI/XhoI sites of pET26b(+) to construct the HlyA-
His6-Tag C-terminus (rHlyA) recombinant protein expres-
sion vector, pER-92. The hlyB ORF gene was PCR amplified
using the primer HlyB-NdeI-FOR (CTAAAACATATGGCT
GACG) and HlyB-XhoI-REV (AATCTGCTCGAGTTTATA
CACG). The 816 nt DNA fragment was cloned into the
NdeI/XhoI sites of pET26b(+) to construct the rHlyB-His6-
Tag C-terminus (rHlyB) recombinant protein expression
vector, pER-91. Bold letters in primer sequences indicate
nucleotide modifications to incorporate the necessary restric-
tion sites underlined. Both rHlyA and rHlyB were overex-
pressed in E. coli Rosetta(DE3)pLys and purified by Ni-NTA
agarose (Qiagen, Inc., Valencia, CA) affinity chromatography
according to the manufacturer’s instructions. Eluted fractions
were collected and analyzed by SDS-PAGE (sodium dodecyl
sulfate polyacrylamide gel electrophoresis). The fractions
containing bands of 32 kDa rHlyB or 38 kDa rHlyA were
pooled and extensively dialyzed against PBS.
Genetic complementation of hlyBA mutant
A 2035 nt DNA fragment containing the promoterless
hlyBA gene from B. fragilis 638R in pER-18 (Robertson
et al. 2006) was digested with BamHI and SstI and cloned
into the Bacteroides–E. coli expression shuttle vector pFD340
(Smith et al. 1992). The new construct, pER-80, was conju-
gated into BER-41 by triparental mating according to stan-
dard protocols (Rocha and Smith 1999). Transconjugants
were selected on BHIS plates containing 20 lg/mL rifamycin,
100 lg/mL gentamycin, and 10 lg/mL erythromycin.
Enzyme-linked immunosorbent assays
High-binding affinity 96-well enzyme-linked immunosor-
bent assay (ELISA) plates (Corning laboratories) were
coated with purified rHlyA A or rHlyB at 4 lg/mL in
50 mmol/L carbonate buffer, pH 9.6. Wells were then
washed two times with PBS to remove unbound proteins.
Then, wells were blocked with 1% BSA in PBS containing
0.05% Tween 20 (PBS-T). Twofold serial dilutions up to
1:128 of cell-free supernatant of peritoneal exudates
collected from the tissue cage model were added to
respective wells and incubated at 37°C for 1 h. Plates
were washed again in PBS-T. The presence of rat
antihemolysin antibodies were detected using goat anti-rat
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IgG peroxidase conjugates (Southern Biotech, Birmingham,
AL). After incubation for 1 h at 37°C and washings,
developing solution containing TMB (3,3′,5,5′-tetrameth-
yl-benzidine; Sigma Co., Saint Louis, MO) was added.
Reactions were stopped with addition of 2 N HCl and
the absorbance of each well was read in a microplate
reader Multiskan Ex (Thermo Electron Corporation, Mil-
ford, MA) at 450 nm.
Results
In this study, we show the adaptation of the large rat tissue
cage model, which consists of intraperitoneal implantation
of the perforated table tennis ball developed by Bamberger
et al. (2002), to establish B. fragilis intraperitoneal abscess
infection. This model of intraperitoneal abscess formation
has been successfully used with Staphylococcus aureus
experimental infections (Bamberger et al. 2002). Consistent
with the description of this model, the ball became encased
in connective tissue, developed a blood supply, and became
filled with sterile fluids with the appearance of serum. In
Figure 1, we show representative pictures of the surgery
implantation of the tissue cage and the encapsulated cage at
the necropsy. The infection process remains confined
within the cage. At the time of necropsies, the rats did not
shown any signs of systemic or localized infection outside
the tissue cage as determined by an independent veterinar-
ian pathologist at the Department of Comparative Medi-
cine. One advantage of this model is that the tissue cage is
large enough to allow repeated sampling of an ongoing
intra-abdominal abscess infection. This repeated sampling
allowed us to obtain B. fragilis cells to extract bacterial
RNA for gene expression studies from the same inoculated
rats in a time course manner. Because very little is known
about gene expression of B. fragilis in vivo, the expression
of hemolysin genes were investigated to determine the
usefulness of this model.
Real-time RT-PCR of hemolysin genes
expressed in vivo
The in vivo expression ratio of eight hemolysin genes
mRNAs in B. fragilis 638R strain was analyzed by real-
time RT-PCR and compared with their respective in vitro
expression ratio. A diagram of the genetic structural orga-
nization for each hemolysin: hlyA, hlyB, hlyC, hlyD, hlyE,
hlyF, hlyG, and hlyIII in the genome of B. fragilis 638R is
presented in Figure 2. In previous study, we have shown
that the hlyB and hlyA genes are expressed as bicistronic
hlyBA mRNA but hlyA is also expressed as single mRNA
(Fig. 2 and Robertson et al. 2006). Therefore, in this





Figure 1. Intraperitoneal tissue cage rat
model. A and B) A sterile perforated “tennis
ping-pong” ball was implanted into the
peritoneal cavity of Sprague Dawley rats
(weight, 400 g). C) Exudate fluid aspirated
from the implanted intraperitoneal perforated
tissue cage ball. D) An exposure of the
encapsulated perforated tissue cage removed
from the peritoneal cavity at the time of
necropsy. Panels do not show pictures to scale.
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measured the expression levels of both hlyBA mRNA and
hlyA mRNA combined while hlyB transcripts were mea-
sured only as hlyBA mRNA. In Figure 3, the expression
ratio of each hemolysin in the intraperitoneal tissue cage
exudate is presented. The hlyA transcripts were reduced
nearly twofold during the first 24 h postinfection. How-
ever, there was an increase of approximately sixfold after
4 days postinfection compared with the mRNA levels
in the inoculum culture and remained higher than three-
fold at 8 day postinfection. The hlyB transcripts increased
approximately threefold after 1 day, 16-fold after 4 days,
and remained elevated at 8 days postinfection. Expression
of hlyC mRNA increased sixfold after 1 day, 45-fold after
4 days, and 16-fold after 8 days postinfection, respec-
tively. Levels of mRNA for hlyD and hlyE were not signif-
icantly altered after 1 day postinfection but were induced
approximately 32-fold after 4-days postinfection. The hlyF
and hlyG mRNAs were not increased significantly after
1 day postinfection and had an approximately three- to
fourfold increase after 4 days postinfection, respectively.
The hlyIII mRNA levels had a steady increase of approxi-
mately four-, eight- and 12-fold following 1, 4, and
8 days postinfection, respectively. Overall, it seems that
B. fragilis hemolysins reached their maximum expression
at 4 days postinfection. These findings show that B. fragi-
lis hemolysins are induced in vivo and are differentially
regulated within the peritoneal cavity at the initial stages
of infection.
Bacterial survival in abscesses
To analyze the role of hemolysin production in the sur-
vival of B. fragilis in extra-intestinal infection, we looked
at the viability of hemolysin mutants: the dual-hemolysin
hlyBA (BER-41), hlyIII (BER-45), and hlyBA hlyIII double
mutant (BER-46) (Robertson et al. 2006). In the initial
24-h period postinfection, the B. fragilis 638R parent
strain and hemolysin mutants had a >10-fold increase in
cell viable counts compared with the inoculum numbers.
However, this was followed by a pronounced decrease in
viability of the hlyBA and hlyBA hlyIII mutants. These
two strains lost 2 logs in cfu numbers within 4 days
postinfection compared with parent strain (Fig. 4). After
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Figure 2. The genetic structure of the hlyA,
hlyB hlyC, hlyD, hlyE, hlyF, hlyG, and hlyIII loci
in the Bacteroides fragilis 638R genome.
Hemolysins ORF and direction of transcription
are depicted by a gray arrow. Open arrows
depict ORFs and transcription orientation of
the genes flanking each respective hemolysin
chromosomal region. The locus tag for each
gene and gene product are shown,
respectively, below and above each ORF. The
transcriptional products for the hlyBA operon
were adapted from Robertson et al. (2006).
The thin dark arrows indicate the direction and
length of the hlyBA bicistronic mRNA and hlyA
monocistronic mRNA. The dark bent arrow
depicts the putative promoter region derived
from Robertson et al. (2006). The bar below
each hemolysin ORF represents the coding
region and length of the PCR products
amplified from cDNAs in the Real-Time RT-PCR
experiments described in the Materials and
Methods section.
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of 1.5 log lower than the parent strain up to 22 days
postinfection. hlyBA hlyIII mutant also remained lower
than the 638R strain. The dual-hemolysin HlyBA alone
had the strongest effect on cell survival and additional
disruption in the hlyIII gene did not have a synergistic
effect in B. fragilis survival in vivo. Because the hemolytic
activity of HlyBA was only determined in heterologous
host strain (Robertson et al. 2006), there was no defini-
tive evidence that the HlyBA proteins were the sole
responsible for erythrocytes lyses. Here, we show that
purified recombinant rHlyA, rHlyB, and the genetic
engineered rHlyB:HlyA fusion protein have hemolytic
activity against sheep erythrocytes (Data S1). Thus, we
believe that the decrease in cell survival in the BER-41
strain is indeed due to the lack of hemolytic activities of
the HlyA and HlyB proteins. The hlyIII mutant had an
apparent intermediate survival rate between the parent
strain and the hlyBA mutant. When genetic complemen-
tation of the dual-hemolysin component HlyBA was
constructed in a multicopy plasmid, it only partially
restored the survival rate of hlyBA mutant in compari-
son to the survival rates found for the parent strain.
This may be due to the fact that extrachromosomal
copies of hlyBA under constitutive expression promoter
control have an adverse effect on bacterial physiological
homeostasis.
ELISA
The ELISA was used to assess IgG antibodies level in the
uninfected and infected tissue cage fluids. Figure 5 shows
the optical density (OD) 450 nm absorbance of the ELISA
for anti-HlyA (Fig. 5A) and anti-HlyB (Fig. 5B) reactive
antibodies detected at dilutions of 1:128 at 8 and 22 days
in the cell-free exudates supernatants compared with the
preinfected transudates from intra-abdominal tissue cages.
There was a low level of background reactive IgG antibodies
against HlyA and HlyB present before bacterial inoculation.
This suggests that conventional specific pathogen-free
raised rats were sensitized to HlyA and HlyB from B. fragilis
Days post-infection Days post-infection
Figure 3. Expression ratio of B. fragilis 6389R hemolysins in vivo. Real-time RT-PCR was carried out from total RNA isolated from the intra-
abdominal infection tissue cage model implanted into rat peritoneal cavity. Real-time RT-PCR was performed for each hemolysin depicted in each
respective panel using specific primers described in the Material and Methods section. hlyA expression levels include both hlyBA bicistronic mRNA
and hlyA monocistronic mRNA combined. hlyB expression was measured as a component of the hlyBA bicistronic mRNA. Data were analyzed
using the Relative Expression Software Tool (REST) V. 2.07 for group-wise comparison and statistical analysis of relative expression. In vivo
expression of hemolysins was normalized to their respective levels of expression in culture media control (CM). 16S rRNA was used as
housekeeping reference RNA. Data are from triplicated real-time RT-PCR reactions in two sets of pooled RNA from two groups of six animals.
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which is present in the rat normal intestinal microflora.
The IgG levels peaked at 8 days for anti-HlyA and anti-
HlyB cross-reactive antibodies in tissue cage infected with
the parent strain. The levels of anti-HlyA and anti-HlyB
antibodies were also elevated in animals inoculated with
the hlyBA mutant strain. The levels of anti-HlyA and anti-
HlyB antibodies were significantly higher in the hlyBA
mutant strain at 22 days postinfection compared with the
levels in the parent strain. It is possible the hlyBA mutant
strain may be physiologically compensating that lack of
hlyBA with production of other hemolysins or proteins of
the acetyltransferase (pfam1344) and acyltransferase
(cd07986) superfamily conserved domains present in HlyA
and HlyB (Robertson et al. 2006). In this regard, the align-
ment of hemolysins deduced amino acid sequences revealed
that there are conserved homologous regions which could
be potential structural or conformational cross-reactive
epitopes (Fig. S1). Thus, we cannot rule out that the ele-
vated levels of IgGs were generated against multiple epi-
topes of B. fragilis antigens cross-reacting with rHlyA or
rHlyB. It is also possible that specific antibodies against
HlyA and HlyB were present in exudates of rats infected
with the parent strain but their levels might have been
masked by the robust response of cross-reacting IgGs anti-
B. fragilis.
Discussion
In this study, we show the adaptation of the confined
large tissue cage rat model to B. fragilis experimental
intra-abdominal abscess formation. This model was
suitable to extract B. fragilis RNA for quantification of
gene expression in vivo. We used this methodology to
determine the expression ratio of B. fragilis hemolysins by
real-time RT-PCR in a time course postinfection. Our
findings show that eight distinct hemolysin genes, hlyA,
hlyB, hlyC, hlyD, hlyE, hlyF, hlyG, and hlyIII, are coordi-
nated and differentially expressed in vivo. This suggests
that production of hemolysins may contribute to B. fragi-
lis pathogenicity during extra-intestinal infection. Consis-
tent with this, we have also demonstrated that in the
absence of the dual-component hemolysin HlyBA, there is
an effect on the ability of B. fragilis to maintain cell
viability at the same levels as the parent strain. In addi-
tion, the findings showing that HlyIII had a lesser survival
effect than HlyBA indicates that they may have differen-
tial role and function in B. fragilis in intra-abdominal
survival. Despite this modest progress in our understanding,
the complete roles of hemolysins in the pathophysiology of
this opportunistic pathogen and intestinal colonizer remain
to be elucidated.
At this point, we assume that the extensive number of
hemolysins in B. fragilis offers an advantage to this anaer-
obe which has a much greater potential to cause infection
than any other anaerobic species that colonize the human
body. In many Gram-positive and Gram-negative bacte-
ria, production of hemolysins or cytolysins is a powerful
virulence factor that results in lysing and killing incoming
leukocytes and other host cells (Welch 1991; Rowe and
Welch 1994; Menestrina et al. 2003). These features not
only promote the survival of the pathogenic microbe by
weakening the immune system but also provide access to
nutrients (Genco and Dixon 2001; Menestrina et al.
2003). In this regard, it is important to mention that
B. fragilis is unable to synthesize protoporphyrin macro-
cycle and has requirement for heme and nonheme iron in
vitro and in vivo (Otto et al. 2002; Rocha and Smith
2010). Thus, the expression and regulation of hlyBA may
promote access to iron and heme in vivo through tissue
cells and erythrocytes damage to overcome the iron-limit-
ing conditions imposed by the host’s iron-withholding
mechanism. This is consistent with our previous report
showing that iron-limiting conditions upregulate the
expression of the hlyBA bicistronic mRNA in a Fur-
dependent manner (Robertson et al. 2006). This is also in
agreement with iron-limiting dependent regulation
mechanism of bacterial hemolysins in many pathogenic
bacteria (Braun 1985; Calderwood and Mekalanos 1987;
Braun and Focareta 1991; Litwin and Calderwood 1993;
Cui et al. 2009; Sineva et al. 2012).
Although very little is known about the mechanisms
that may be involved in the regulation of all the B. fragilis
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Figure 4. Survival of B. fragilis strains inoculated into the
encapsulated intraperitoneal implanted tissue cage as described in
Figure 1. Fluid exudates were aspirated for viable cell counts (cfu) at
time points indicated. : B. Fragilis 638R parent strain (n = 6). :
BER-41 DhlyBA::teQ deletion mutant (n = 6). : BER-45 DhlyIII::cfxA
deletion mutant (n = 3). : BER-46 DhlyBA::teQ DhlyIII::cfxA double
mutant (n = 3). : BER-47: DhlyBA::teQ pER-80 (n = 3).
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addressed here is the fact that molecular oxygen has a
strong inhibitory effect on the expression of both hlyBA
bicistronic mRNA and hlyA monocistronic mRNA
(Robertson et al. 2006). These findings may be correlated
with the fact that proliferation of B. fragilis occurs after
the establishment of anaerobic conditions in extra-intesti-
nal infection following reduction of oxygen at the site of
infection (Sawyer et al. 1991; Rotstein 1993; Rocha et al.
2007; Sund et al. 2008). In this regard, we assume that
the low level of expression of hemolysin, as far as HlyBA
is concerned, within the first 24 h postinfection, com-
pared with higher level of expression at 4- and 8-days
postinfection, may be indicative of an adaptive period to
the transition from aerobic to anaerobic infection mode.
These findings agree with recent reports demonstrating
that aerotolerance and oxidative stress response are the
essential mechanisms for B. fragilis proliferation at the
initial stages abscess formation in extra-intestinal oxygen-
ated tissues till adequate anaerobic conditions are formed
for expression of virulence factors to maintain an infec-
tious process (Rocha et al. 2007; Sund et al. 2008; Reott
et al. 2009).
We show the presence of low level of IgG antibodies
reactive against B. fragilis rHlyA and rHlyB proteins in
the transudate aspirated from the encased “ping-pong”
ball tissue cage prior to bacterial inoculation as deter-
mined by ELISA. It is likely that the adult conventionally
raised rats were sensitized to B. fragilis that normally
colonized the intestinal tract. However, the increase in the
levels of IgGs anti-HlyA and anti-HlyB detected in the
exudates infected with parent or hlyBA deletion mutant
strains indicates that these are cross-reactive IgGs anti-
bodies. The rapid and strong increase in IgGs following
bacterial inoculation may have triggered secondary
systemic immune response to B. fragilis multiantigens
producing IgGs antibodies that cross-react against HlyA
and HlyB. Nonetheless, the upregulation of hlyBA mRNA
synthesis in vivo confirms that they are produced/secreted
in extra-intestinal infections. We assume that the presence
of polyclonal antibodies reactive to B. fragilis HlyA and
HlyB prior to infection may be the result of the possible
intestinal mucosal exposure of B. fragilis antigens present
in the normal intestinal flora in healthy conventional
experimental rodents. In experimental infection in adult
rabbits, a rapid rise in the levels of IgG antibodies anti-
Bacteroides antigens has been reported. The inoculation of
B. fragilis into rabbit sinuses induced rapid and rigorous
secondary immune responses initiated by memory T cells
that are recruited to the site of pathogen antigen exposure
(Jyonouchi et al. 1999). The adult rabbits were likely to
be sensitized to B. fragilis antigens which is present in the
normal rabbit intestinal flora prior to bacteria inoculation
(Jyonouchi et al. 1999). The interpretation of our results
is further complicated by the fact that membranous struc-
ture enveloping tissue implanted devices to create artifi-
cial body cavities select for classes of immunoglobulins
and serum proteins. In particular, IgG molecules with
antibody activity against specific inoculated antigens may
be selectively excluded to penetrate in artificial body
cavities (Klein et al. 1976). The presence of systemic and
localized mucosal immune responses to B. fragilis and
B. thetaiotaomicron antigens colonizing the intestinal tract
has being largely reported in both conventional and
germ-free monoassociated experimental rodent models
(Jyonouchi et al. 1999; Scharek et al. 2000; Peterson et al.






















Figure 5. Detection of Rat IgG antibodies reactive against rHlyA and rHlyB by enzyme-linked immunosorbent assay (ELISA). IgG levels reactive
against rHlyA (panel A) or rHlyB (panel B) in the transudate preinfection (n = 3) and exudate fluids (n = 3) aspirated from the implanted tissue
cage balls at 8 days and 22 days postinfection. Bf 638R: B. fragilis 638R parent strain. BER-41 DhlyBA::tetQ deletion mutant. Microsoft Excel
T-TEST software was used to calculate the paired two-tailed Student t-test to determine the statistical significance between groups. Group
differences were considered statistically significant for P-value <0.05. The numbers above horizontal brackets in panels A and B are the probability
values associated with the Student t-test.
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sented or exposed to local and systemic immune system
through intact mucosal barrier is not completely under-
stood. It is not our objective to discuss at all the complex
equilibrium of the inter-relationship between the host
mucosal immune system and the intestinal microflora
components. For this subject, a wide range of reports are
available (Chow et al. 2010; Hooper et al. 2012; Nishio
and Honda 2012).
Production of hemolysins/cytolysins by gastrointestinal
colonizers and opportunistic pathogens is not only
important for systemic infections but also may provide a
competitive advantage in the highly competitive intestinal
ecological system (Coburn and Gilmore 2003; Cox et al.
2005; Robertson et al. 2006; Rocha and Smith 2010). In
this regard, it has been suggested that variations in heme
availability in human intestinal tract may affect the
growth of Bacteroides because of its effect on their short-
chain fatty acids fermentation pathway products (Rocha
and Smith 2010). Thus, it is possible that B. fragilis
hemolysins such as HlyA and HlyB may sublethally injure
the intestinal mucosal cells to enhance access to this
essential heme as nonpathological microbleeding and/or
epithelial desquamation are sources of luminal heme
(Young et al. 1989). This nonpathological sublethal injury
may help the heme-requiring intestinal predominant bac-
teria such as Bacteroides spp. to acquire essential heme.
Through this process, it may expose indigenous Bactero-
ides multiantigens to host immune system but this
assumption has not yet been tested experimentally.
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